Capital-E

Capital-E, established in 2006, is a venture capital firm based in Antwerp, Belgium. It specializes in early-stage investments, providing capital to companies developing innovative electronics or advanced materials-based products. The firm leverages its strategic relationship with IMEC, Europe's largest independent research center in micro- and nano-electronics, to offer portfolio companies access to over 2000 scientists and engineers, as well as IMEC's extensive global partner network. Capital-E invests across Western Europe, focusing on sectors such as semiconductor, materials, processing, and consumer electronics.

Lou Hermans

Partner

Pascal Vanluchene

Co-Founder and Venture Partner

Marc Wachsmuth

Co-Founder and Managing Partner

Past deals in Belgium

Accelleran

Series B in 2021
Accelleran, founded in 2013 and headquartered in Antwerp, Belgium, specializes in delivering Open RAN-aligned Private 5G networks tailored for enterprises of all sizes. The company focuses on providing an economically viable alternative to traditional mobile telecom solutions through its open and containerized radio access network (RAN) software. Accelleran’s offerings leverage cloud-native techniques that enhance flexibility, innovation, and scalability while maintaining hardware independence. By facilitating the deployment of multi-vendor, disaggregated Private 5G networks akin to WiFi, Accelleran empowers businesses to achieve real-time network control, automation, and an enhanced user experience. Through collaboration with a diverse ecosystem of partners, the company is positioned to support both private and public network needs effectively.

Accelleran

Series A in 2016
Accelleran, founded in 2013 and headquartered in Antwerp, Belgium, specializes in delivering Open RAN-aligned Private 5G networks tailored for enterprises of all sizes. The company focuses on providing an economically viable alternative to traditional mobile telecom solutions through its open and containerized radio access network (RAN) software. Accelleran’s offerings leverage cloud-native techniques that enhance flexibility, innovation, and scalability while maintaining hardware independence. By facilitating the deployment of multi-vendor, disaggregated Private 5G networks akin to WiFi, Accelleran empowers businesses to achieve real-time network control, automation, and an enhanced user experience. Through collaboration with a diverse ecosystem of partners, the company is positioned to support both private and public network needs effectively.

Trinean

Venture Round in 2012
Trinean is a Belgium-based technology provider specializing in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers for biomolecule quantification. Their flagship products, the DropSense™16 and DropSense™96, analyze up to 16 and 96 samples respectively, utilizing microfluidic chips for standardized sample analysis through DropPlates™ and Slides. Trinean's platform is enhanced with a software toolbox designed to improve data interpretation and lab automation, catering to the needs of biologics researchers.

PharmaDiagnostics

Series B in 2010
PharmaDiagnostics NV is a Belgian company specializing in the development of analytical techniques aimed at enhancing the drug discovery process. Based in Zellik, the company offers a range of assays tailored for the pharmaceutical and biotech sectors, including human albumin binding, human orosomucoid, membrane, and redox potential assays. Additionally, PharmaDiagnostics provides assay systems that encompass experimental pKa, experimental log D, P-glycoprotein interaction, Cytochromes P450 interactions, and the solubility of new chemical entities under both fasted and fed intestinal conditions. Through its innovative solutions, PharmaDiagnostics plays a crucial role in supporting drug development efforts.

PharmaDiagnostics

Series B in 2009
PharmaDiagnostics NV is a Belgian company specializing in the development of analytical techniques aimed at enhancing the drug discovery process. Based in Zellik, the company offers a range of assays tailored for the pharmaceutical and biotech sectors, including human albumin binding, human orosomucoid, membrane, and redox potential assays. Additionally, PharmaDiagnostics provides assay systems that encompass experimental pKa, experimental log D, P-glycoprotein interaction, Cytochromes P450 interactions, and the solubility of new chemical entities under both fasted and fed intestinal conditions. Through its innovative solutions, PharmaDiagnostics plays a crucial role in supporting drug development efforts.

CMOSIS nv

Series B in 2009
CMOSIS nv, founded in 2007 and based in Antwerp, Belgium, specializes in the development and supply of advanced CMOS image sensors tailored for professional, scientific, and industrial applications. The company offers a range of products, including standard off-the-shelf sensors, customized solutions, and miniature camera modules, catering to various sectors such as machine vision, biometrics, medical equipment, and space exploration. CMOSIS nv provides comprehensive services that encompass sensor design, prototyping, characterization, packaging, and volume production. Its image sensors are utilized in diverse applications, including 3D imaging, video broadcasting, security, motion capture, and automotive technologies. In addition to its headquarters in Belgium, CMOSIS operates facilities in Nuremberg, Germany; Funchal, Portugal; and Cary, North Carolina, and distributes its products through a network of representatives and distributors globally.

Trinean

Venture Round in 2008
Trinean is a Belgium-based technology provider specializing in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers for biomolecule quantification. Their flagship products, the DropSense™16 and DropSense™96, analyze up to 16 and 96 samples respectively, utilizing microfluidic chips for standardized sample analysis through DropPlates™ and Slides. Trinean's platform is enhanced with a software toolbox designed to improve data interpretation and lab automation, catering to the needs of biologics researchers.

CMOSIS nv

Series A in 2008
CMOSIS nv, founded in 2007 and based in Antwerp, Belgium, specializes in the development and supply of advanced CMOS image sensors tailored for professional, scientific, and industrial applications. The company offers a range of products, including standard off-the-shelf sensors, customized solutions, and miniature camera modules, catering to various sectors such as machine vision, biometrics, medical equipment, and space exploration. CMOSIS nv provides comprehensive services that encompass sensor design, prototyping, characterization, packaging, and volume production. Its image sensors are utilized in diverse applications, including 3D imaging, video broadcasting, security, motion capture, and automotive technologies. In addition to its headquarters in Belgium, CMOSIS operates facilities in Nuremberg, Germany; Funchal, Portugal; and Cary, North Carolina, and distributes its products through a network of representatives and distributors globally.

AsicAhead

Series B in 2007
AsicAhead NV is a fabless semiconductor company based in Genk, Belgium, with additional offices in Mountain View, California, and Godalming, United Kingdom. Founded in 2003, the company specializes in the development of integrated circuits designed for mobile, wireless, and wire-line communications. AsicAhead offers a range of radio frequency silicon solutions, including zero-IF radio architectures, on-chip analog tunable filtering, transmitter loops, and both analog and digital converters. Its products cater to various wireless applications, such as those utilized in global systems for mobile communication, wireless local area networks, Bluetooth, and ultra-wideband technologies. AsicAhead operates as a subsidiary of AnSem N.V. as of August 2008.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.